Endotheliumprotectiv and antihypoxic properties of quercetin in elderly patients with metabolic syndrome
DOI:
https://doi.org/10.14739/2310-1210.2021.2.228707Keywords:
metabolic syndrome, elderly age, quercetin, functional state of the endothelium, hypoxiaAbstract
Aim: To investigate the effectiveness of course quercetin in improving functional state of the microvascular endothelium and to determine the possibility of using quercetin to increase body resistance to hypoxia in the elderly.
Materials and methods. The effectiveness of quercetin in improving the functional state of the endothelium and increasing body resistance to hypoxia was studied in 110 elderly patients with metabolic syndrome, who were divided equally into the main and control groups. Patients in the main group received quercetin at a daily dose of 240 mg for 3 months, and patients in the control group received placebo for the same period. Before and after treatment, the microvascular endothelial function was studied by laser Doppler flowmetry using the post-occlusive hyperemia test. Acute hypoxic test was performed under isocapnicnormobaric hypoxia, during which the followings were recorded: blood saturation (SpO2), heart rate and diastolic blood pressure (BP).
Results. In the group of patients receiving quercetin, there was an improvement in blood flow to the skin, as evidenced by a statistically significant increase in the maximum volumetric rate of cutaneous blood flow and the duration of the recovery period of OSHSK to baseline in the post-occlusive hyperaemia.
The course of quercetin also led to a less significant decrease in SpO2 during hypoxic test and to a decrease in the absolute values of systolic and diastolic blood pressure, while reducing an increase of the systolic blood pressure on the 20th min of the hypoxic test.
Conclusions. In elderly patients with metabolic syndrome (within a 3 month course) the use of quercetin has improved the microvascular endothelium functional status and increased the resistance to hypoxia.
References
Flammer, A. J., Anderson, T., Celermajer, D. S., Creager, M. A., Deanfield, J., Ganz, P., Hamburg, N. M., Lüscher, T. F., Shechter, M., Taddei, S., Vita, J. A., & Lerman, A. (2012). The Assessment of Endothelial Function: From Research Into Clinical Practice. Circulation, 126(6), 753-767. https://doi.org/10.1161/CIRCULATIONAHA.112.093245
Matsuzawa, Y., & Lerman, A. (2014). Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coronary Artery Disease, 25(8), 713-724. https://doi.org/10.1097/MCA.0000000000000178
Pi, X., Xie, L., & Patterson, C. (2018). Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. Circulation Research, 123(4), 477-494. https://doi.org/10.1161/CIRCRESAHA.118.313237
Babik, B., Peták, F., Agócs, S., Blaskovics, I., Alács, E., Bodó, K., & Südy, R. (2018). Diabetes mellitus: endotheldiszfunkció és haemostasiselváltozások. Orvosi Hetilap, 159(33), 1335-1345. https://doi.org/10.1556/650.2018.31130
Zharinova, V. Y., Bodretskaya, L., Duzhak, G., Samots, S. I., Shapovalenko, I., & Voinarovskaya, G. (2018). Functional State of Endothelium in Aging. Gerontology & Geriatrics Studies, 2(5), 191-194. https://doi.org/10.31031/GGS.2018.02.000548
Korkushko, O. V., & Ivanov, L. A. (1980). Gipoksiya i starenie [Hypoxia and aging]. Naukova dumka. [in Russian].
Wong, B. W., Marsch, E., Treps, L., Baes, M., & Carmeliet, P. (2017). Endothelial cell metabolism in health and disease: impact of hypoxia. The EMBO Journal, 36(15), 2187-2203. https://doi.org/10.15252/embj.201696150
Mykhailovska, N. S., & Oliinyk, T. V. (2016). Dynamika rivniv imunozapalnykh markeriv na tli terapii kvertsetynom u khvorykh na ishemichnu khvorobu sertsia, asotsiiovanu z hipotyreozom [Dynamics of immunoinflammatory markers level on the background of quercetin therapy in patients with ischemic heart disease associated with hypothyroidism]. ScienceRise, 1(3), 32-36. https://doi.org/10.15587/2313-8416.2016.59038 [in Ukrainian].
Parshykov, O. V., Utko, N. O., & Gorban, E. M. (2019). Vplyv kvertsetynu (Kvertynu) na vidnovlennia NO-zalezhnykh reaktsii sudyn za uchastiu endoteliiu ta peryvaskuliarnoi zhyrovoi tkanyny v shchuriv pislia renthenivskoho oprominennia [Effect of quercetin (Quertin) on NO-dependent reactions of rat blood vessels with participation of endothelium and perivascular adipose tissue after X-ray exposure]. Farmakolohiia ta likarska toksykolohiia, 13(4), 277-285. https://doi.org/10.33250/13.04.277 [in Ukrainian].
Lozano, O., Lázaro-Alfaro, A., Silva-Platas, C., Oropeza-Almazán, Y., Torres-Quintanilla, A., Bernal-Ramírez, J., Alves-Figueiredo, H., & García-Rivas, G. (2019). Nanoencapsulated Quercetin Improves Cardioprotection during Hypoxia-Reoxygenation Injury through Preservation of Mitochondrial Function. Oxidative Medicine and Cellular Longevity, 2019, Article 7683051. https://doi.org/10.1155/2019/7683051
Chiş, I. C., Baltaru, D., Dumitrovici, A., Coseriu, A., Radu, B. C., Moldovan, R., & Mureşan, A. (2018). Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat's heart. Physiology International, 105(3), 233-246. https://doi.org/10.1556/2060.105.2018.3.23
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., Loda, M., Looney, M. R., McAllister, F., Rayes, R., Renaud, S., Rousseau, S., Salvatore, S., Schwartz, R. E., Spicer, J. D., Yost, C. C., … Egeblad, M. (2020). Targeting potential drivers of COVID-19: Neutrophil extracellular traps. Journal of Experimental Medicine, 217(6), Article e20200652. https://doi.org/10.1084/jem.20200652
Wang, L., Chen, J., Wang, B., Wu, D., Li, H., Lu, H., Wu, H., & Chai, Y. (2014). Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Experimental Biology and Medicine, 239(12), 1653-1662. https://doi.org/10.1177/1535370214537743
Mahase, E. (2020). Covid-19: what treatments are being investigated? BMJ, 368, Article m1252. https://doi.org/10.1136/bmj.m1252
Gilmore, T. D., & Herscovitch, M. (2006). Inhibitors of NF-κB signaling: 785 and counting. Oncogene, 25(51), 6887-6899. https://doi.org/10.1038/sj.onc.1209982
Weng, Z., Zhang, B., Asadi, S., Sismanopoulos, N., Butcher, A., Fu, X., Katsarou-Katsari, A., Antoniou, C., & Theoharides, T. C. (2012). Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLOS ONE, 7(3), Article e33805. https://doi.org/10.1371/journal.pone.0033805
Iskender, H., Dokumacioglu, E., Sen, T. M., Ince, I., Kanbay, Y., & Saral, S. (2017). The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomedicine & Pharmacotherapy, 90, 500-508. https://doi.org/10.1016/j.biopha.2017.03.102
Mitchenko, O. I., Korpachev, V. V., Bahrii, A. E., Zviahina, T. V., Koval, S. M., Kovalova, O. M., Lutai, M. I., Mankovskyi, B. M., Pankiv, V. I., Svishchenko, Ye. P., Sirenko, Yu. M., Sokolova, L. K., & Talaieva, T. V. (2009). Diahnostyka i likuvannia metabolichnoho syndromu, tsukrovoho diabetu, prediabetu i sertsevo-sudynnykh zakhvoriuvan [Diagnosis and treatment of metabolic syndrome, diabetes, prediabetes and cardiovascular disease]. Kyiv. http://strazhesko.org.ua/upload/2014/02/20/metodichka_a5_-n1402-_ua.pdf [in Ukrainian].
Zeka, K., Ruparelia, K., Arroo, R., Budriesi, R., & Micucci, M. (2017). Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes. Diseases, 5(3), Article 19. https://doi.org/10.3390/diseases5030019
Sánchez, M., Galisteo, M., Vera, R., Villar, I. C., Zarzuelo, A., Tamargo, J., Pérez-Vizcaíno, F., & Duarte, J. (2006). Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. Journal of Hypertension, 24(1), 75-84. https://doi.org/10.1097/01.hjh.0000198029.22472.d9
Patel, R. V., Mistry, B. M., Shinde, S. K., Syed, R., Singh, V., & Shin, H.-S. (2018). Therapeutic potential of quercetin as a cardiovascular agent. European Journal of Medicinal Chemistry, 155, 889-904. https://doi.org/10.1016/j.ejmech.2018.06.053
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395(10234), 1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
Korkushko, O. V., Naskalova, S. S., Antonyuk-Shcheglova, I. A., Duzhak, G. V., Bondarenko, O. V., Grib, O. M., & Shatilo, V. B. (2019). Vplyv kvertsetynu na reolohichni vlastyvosti krovi v patsiientiv pokhyloho viku z metabolichnym syndromom [Quercetine influence on the resological properties of blood for elderly patients with metabolic syndrome]. Ukrainskyi kardiolohichnyi zhurnal, 26(3), 71-77. http://doi.org/10.31928/1608-635X-2019.3.7177 [in Ukrainian].
Korkushko, O. V., Shatilo, V. B., Antoniuk-Shcheglova, I. A., Naskalova, S. S., Bondarenko, O. V., & Grib, O. M. (2020). Vplyv kvertsetynu na pokaznyky vuhlevodnoho ta lipidnoho obminu u liudei pokhyloho viku z metabolichnym syndromom [Effect of quercetin on the indicators of carbohydrate and lipid metabolism in elderly people with metabolic syndrome]. Problemy endokrynnoi patolohii, (1), 36-40. https://doi.org/10.21856/j-PEP.2020.1.05 [in Ukrainian].
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
